Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jens Schreiber (Magdeburg, Germany), Jens Schreiber, Kristin Garg, Claudia Mailaender. X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients. Eur Respir J 2016; 48: Suppl. 60, 4166

Member's Comments

No comment yet.

Related content which might interest you: Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study Source: International Congress 2016 – Asthma points to ponder Year: 2016 Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes Source: International Congress 2016 – Airway stenting and ablation Year: 2016 One year dynamics of life quality depending on the adherence to therapy in patients with bronchial asthma Source: Annual Congress 2013 –Asthma at the bedside Year: 2013 Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study Source: International Congress 2016 – Asthma management Year: 2016 Patient-reported outcomes as predictors of COPD exacerbations - a prospective study Source: International Congress 2014 – COPD markers Year: 2014 The control of asthma in real life: Baseline evaluation of a long-term study Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 The impact of anxiety and depression on asthma-related health outcomes: A prospective study Source: International Congress 2015 – Asthma mechanisms and management Year: 2015 APEXII- A prospective study investigating the efficacy of omalizumab treatment in severe allergic asthma Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Factors associated with patient perspective outcomes in a cohort of asthmatics Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Factors influencing to HRQOL of patients with mild to moderate persistent asthma in Japan; sub-analysis of GAIA study Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Predicting asthma exacerbations in children – A real life observational study Source: International Congress 2015 – Highlights in paediatric epidemiology: air pollution, asthma and primary ciliary dyskinesia Year: 2015 Does one year change in quality of life predict the mortality in patients with COPD?: Prospective cohort study Source: Annual Congress 2013 –Quality of life and respiratory symptoms in primary care COPD populations Year: 2013 A prospective observational study of the impact of COPD on daily life following the initiation of indacaterol Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Effect of an individualized education program on asthma control and health-related quality of life in adult asthma patients: A prospective study Source: International Congress 2016 – Abstracts in medical education, the web and the internet Year: 2016 4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Short-term evaluation of a remote patient support program in patients with COPD and frequent exacerbations. ESOPO study Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 LATE-BREAKING ABSTRACT: One-year assessment of asthma control and quality of life in Europe: The liaison study (international cross-sectional and longitudinal assessment on asthma control) Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 Effectiveness of omalizumab in Canadian patients with allergic asthma: A retrospective study. Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside Year: 2017